MS Academy
The MS Academy is a medical education initiative by Bayer AG. The 2021 program focussed on the current hot topics of clinical vulnerability and vaccination in MS and was chaired by Professor Mar Tintore, CEMCAT, University Hospital Vall d'Hebron, Barcelona, Spain.
References
- Vaughn CB et al. Nat Rev Neurol 2019; 15(6): 329-42. Return to content
- Daltrozzo T et al. Front Neurol 2018; 9: 871. Return to content
- UK Government. MS data briefing, February 2020. Available at: https://www.gov.uk/government/publications/multiple-sclerosis-prevalenceincidence-and-smoking-status Return to content
- Wallin MT et al. Neurology 2019; 92(10): e1029-40. Return to content
- Mills EA, Mao-Draayer Y. Mult Scler 2018; 24(8): 1014-22. Return to content
- Montgomery S et al. Europ J Neurol. 2013; 20: 1153–1160. Return to content
- Marrie RA et al. Neurology 2014; 83: 929–937. Return to content
- Wijnands JMA et al. Mult Scler. 2017; 23: 1506–1516. Return to content
- Luna G et al. JAMA Neurol 2020; 77(2): 184-91 Return to content
- Möhn N et al. Front Immunol 2020; 11: 1059. Return to content
- Jakimovski D et al. Vaccines (Basel). 2020 Jan 28;8(1):50. Return to content
- Zrzavy T et al. Front Immunol. 2019 Aug 7;10:1883. Return to content
- Lebrun C et al. Mult Scler Relat Disord. 2019 Jun; 31: 173-188. Return to content
- Farez MF et al. Neurology. 2019 Sep 24; 93(13): 584-594. Return to content
- Otero-Romero S et al. Neurologia. 2020 Jun 17:S0213-4853(20)30045-1. Return to content
